Introduction
============

Noncommunicable diseases (NCDs) and chronic illnesses affect all countries, including the Gulf Cooperation Council (GCC) countries, of which the State of Qatar is a member. The increase in prevalence of NCDs is largely attributable to changing demographics and adoption of the lifestyle of developed countries, ie, poor (high fat, high sugar) diet and insufficient exercise.[@b1-ceor-7-377] It is well recognized that people suffering from NCDs have intensive and often costly health care needs.

It is a widely held view that countries with higher levels of national wealth have better health outcomes in terms of a healthier lifestyle, better diet, and access to better health care services.[@b2-ceor-7-377],[@b3-ceor-7-377] However, increased wealth can also have a negative impact on health as a result of poor lifestyle choices. This has been seen in the Western world through an increase in obesity, lack of exercise, and excessive energy consumption. Increasing prosperity around the world has led to a new wave of negative health impacts. It is therefore necessary to evaluate the increasing prevalence of NCDs, such as respiratory illness, cardiovascular diseases, and cancer, in the GCC countries in order to formulate appropriate responses.

Defining NCDs
=============

NCDs are defined as diseases of "long duration, generally with slow progression".[@b4-ceor-7-377] The leading NCDs are generally considered to be cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases.[@b5-ceor-7-377] Whilst these diseases are the main NCDs affecting world health, they do not cover all disease entities, with notable omissions being mental health disorders, vision and hearing impairments, and musculoskeletal diseases. Musculoskeletal diseases alone "can severely diminish one's capacity to undertake manual labor, such as farming, which is the dominant productive activity in rural settings that are home to 50% of the world's population".[@b6-ceor-7-377] Further, the term "noncommunicable disease" may be regarded as somewhat of a misnomer, given that a proportion of NCDs can be transmitted from human to human, an example of this being human papillomavirus.[@b7-ceor-7-377]

Burden of NCDs on health and well-being
=======================================

Overall, chronic NCDs were responsible for around 68% of the 56 million deaths recorded across the globe in 2012.[@b4-ceor-7-377] [Figure 1](#f1-ceor-7-377){ref-type="fig"} shows the World Health Organization (WHO) classification of the four main NCDs, ie, cardiovascular diseases, chronic lung diseases, cancer, and diabetes, in terms of causes of death in 2012.[@b4-ceor-7-377] In that year, cardiovascular disease alone was responsible for around 7.4 million deaths, respiratory cancers for 1.6 million (2.7%) deaths, and diabetes for 1.5 million (2.7%) deaths.

The same WHO statistics show that approximately 75% of deaths attributable to NCDs occurred in low-income or middle-income countries. However, in relation to the percentage of deaths per country, ie, compared with the size of population, the most developed countries actually had the highest incidence (87%) of all deaths from NCDs, followed by upper middle-income countries (81%).[@b4-ceor-7-377]

The impact of NCDs is steadily increasing, and is affecting people of all ages in both developed and developing countries. According to WHO projections, deaths attributable to NCDs have increased globally by 7 million between 2000 and 2012.

From a standard of living perspective, NCDs tend to result in further impairments to the individual over time. The absolute numbers vary from study to study, but for diabetes it is estimated that "... between 13% to 65% ... will develop neuropathy, leading to chronic ulcerations and amputations in 1% to 17% of them; 10% to 47% of persons"living with diabetes will develop a retinopathy leading to visual impairment.[@b8-ceor-7-377] These numbers become even more alarming when it is considered that the same research found that "... in 2004, there were 30.7 millions of people in the world living with impairments due to stroke, one of the conditions caused by cardiovascular risk factors". In broader terms, the effects on these individuals are far reaching, and "... they may be considered to have a disability when social, economic, political or other barriers hinder their full and effective participation in society.[@b8-ceor-7-377]"

According to the Global Health Estimates study,[@b9-ceor-7-377] NCDs are among the top ten causes of disability-adjusted life years. In relation to the global view of NCDs, heart disease ranked first in the list (6.0%) in terms of disability-adjusted life years, followed by COPD (3.4%), depressive disorders (2.8%), and respiratory cancer (1.4%).

It is believed that population health has been negatively affected as a result of the economic development currently taking place in GCC countries, ie, "... adopting a sedentary lifestyle among other unhealthy habits", which in turn has led to an increase in NCDs.[@b10-ceor-7-377] It must be noted that whilst the issue is potentially more acute in the GCC region, this pattern mirrors global trends, with projections suggesting that NCDs will cause over 75% of all deaths globally by 2030.[@b10-ceor-7-377]

The top ten causes of death in high-income countries and the GCC region were found to be comparable, as shown in [Figure 2](#f2-ceor-7-377){ref-type="fig"}.[@b4-ceor-7-377] The data in this figure indicate that the disease burden in the GCC region is similar to the global burden, in that ischemic heart disease, which is first on the list, is responsible for 158 deaths per 100,000 population, followed by stroke, which accounts for around 95 deaths per 100,000 population.[@b4-ceor-7-377] When relating these data to Qatar, it can be seen that the overall number of deaths declined between 2001 and 2007. This coincided with an increase in life expectancy from 77 in 2000 to 79 in 2012.[@b9-ceor-7-377] This overall reduction in the actual number of deaths and the increase in life expectancy in Qatar (and in other GCC countries) "... reflect\[s\] the fact that Qatar has entered the epidemiological transition stage three; the age of non-communicable disease.[@b11-ceor-7-377]"

In Qatar, NCDs have been the leading cause of death in the last 10 years. The Qatar STEPS report on risk factors for chronic disease highlighted that, during the period 2004--2010, the top four NCDs in terms of cause of death ([Figure 3](#f3-ceor-7-377){ref-type="fig"}) were "... diseases of the circulatory system, neoplasm, endocrine, nutritional and metabolic diseases, diseases of the respiratory system.[@b11-ceor-7-377]"

According to the Global Health Estimates study in 2011, NCDs are among the ten leading causes of disability-adjusted life years in the Eastern Mediterranean region, including the GCC countries.[@b4-ceor-7-377]

Economic burden of NCDs
=======================

The concept of direct and indirect effects on health has led to consideration of the economic burden of NCDs, and work to date indicates that NCDs have a significant financial impact.[@b10-ceor-7-377] Direct costs are "... associated with the treatment of patients, such as consultations, medications, and clinical operations",[@b14-ceor-7-377] whereas indirect economic impacts have more far-reaching consequences that "... reduce life expectancy, this means less output affect and causes less contribution in economic activities. Labor productivity is diminished due to workers inefficiency and constant absence.[@b11-ceor-7-377]"

Estimating the size of these direct and indirect burdens of disease is difficult because of the range of measurement methods used.[@b10-ceor-7-377] In the World Economic Forum and Harvard School of Public Health study, the economic burden of NCDs was estimated using the cost of illness, EPIC (value of lost output), and value of statistical life models. An econometric model was developed during the study to calculate the cost of illness.[@b6-ceor-7-377] This model is based on information that is more robust and readily available (such as the prevalence rates of the main NCDs), so the conclusions drawn can be regarded as more robust. Again, it should be noted that whilst the NCDs highlighted have different symptoms, they do share common lifestyle-related risk factors.

The total direct and indirect costs calculated for the five selected NCDs in 2013 was \$36.2 billion for the GCC region ([Figure 4](#f4-ceor-7-377){ref-type="fig"}), which is 1.5 times the official health care spending.[@b10-ceor-7-377] The authors of the study also commented that if governments and policymakers do not intervene, up to \$68 billion could be consumed by 2022. The burden is greater, and clearly less sustainable, when the total cost of NCDs is compared with health care spending.

The study predicted that, by 2022, the total cost per head for NCDs alone will reach \$2,778 in Qatar, compared with \$603 in Oman. This is all the more alarming when it is considered that the OECD (Organisation for Economic Co-operation and Development) countries spent \$3,327 per capita on all health care in 2011.[@b10-ceor-7-377] A study by Chahine et al found that the direct cost for the five selected NCDs would be approximately \$6 billion in 2013 for the whole GCC, and projected this to escalate to \$12.9 billion over the following 9 years.[@b10-ceor-7-377]

[Figure 5](#f5-ceor-7-377){ref-type="fig"} highlights the effect of NCDs on the various components of the health economy, and this information should be used to plan future health systems and capacity. The direct costs indicate a large rise in outpatient activity but virtually no impact on hospital admissions, suggesting that whilst more clinic appointments will be required, a subsequent increase in bed numbers will not be necessary for these NCDs ([Figure 5](#f5-ceor-7-377){ref-type="fig"}).

The cost of NCDs was presented comprehensively in the work undertaken by the World Economic Forum and Harvard School of Public Health in 2011.[@b6-ceor-7-377] Three separate methods were used to calculate the burden of direct and indirect costs ([Table 1](#t1-ceor-7-377){ref-type="table"}).[@b6-ceor-7-377] The first method was the cost-of-illness approach, which highlights the economic impact of disease by adding together the direct costs (eg, cost of treatment) and indirect costs (eg, absence from work) associated with an NCD. The second method is the economic growth approach, which is the value of lost output (in terms of economic activity). The final measure is the value of statistical life approach, which calculates the likelihood that people would pay to eliminate or reduce the effects of an NCD on their health.

The various methods highlighted have very separate inputs and therefore should not be used to evaluate the economic impact or one measure against another. Additionally, implementing each of these methods requires making various assumptions whilst recognizing that there are several issues with data quality from GCC sources.[@b11-ceor-7-377] However, the various methodologies are obviously the scale of impact of NCDs and the undoubtedly significant impact on health expenditure.

The World Economic Forum and the Harvard School of Public Health report reached some important conclusions. Firstly, the global output will suffer considerably, with richer countries suffering more financial burden than poorer countries.[@b5-ceor-7-377] Secondly, mental health conditions and cardiovascular diseases cost society the most, perhaps without this being widely recognized in the case of mental health.

Prioritization strategy
=======================

For the purposes of analyzing the potential impact of the four leading NCDs in the GCC region, including Qatar, mortality and disability-adjusted life years ([Table 3](#t3-ceor-7-377){ref-type="table"}) and economic burden ([Table 4](#t4-ceor-7-377){ref-type="table"}) have been used. This exercise will help the government to allocate financial and health resources, to prevent NCDs, identify people at risk and screen them, address the causes of NCDs, and prevent their complications.

However, cardiovascular disease is the leading cause of mortality and disability in the region, and mental and behavioral disorders are the second cause of disability. Cancer is ranked as the second cause of mortality and the third cause of disability, while respiratory diseases rank third as a cause of mortality and the third cause of disability. Mental health and cardiovascular disease account for almost 70%, based on the EPIC model and shown in [Figure 6](#f6-ceor-7-377){ref-type="fig"} (these numbers represent a global figure, but the same ranking applies in GCC countries). The costs incurred by these diseases are shown in [Table 2](#t2-ceor-7-377){ref-type="table"}.[@b6-ceor-7-377]

Conclusion and recommendations
==============================

This work highlights the significant current and future impact of NCDs for Qatar and the wider region, as compared with the worldwide impact.[@b13-ceor-7-377] This will still be a significant financial burden for the region despite the fact that healthcare expenditure is predicted to reach US\$60 billion by 2025.[@b14-ceor-7-377] The above discussion, on the whole, sets aside the impacts to the individual and their families brought about by the effects of long-term conditions and NCDs. These impacts should be sufficient to mandate governments to take action against NCDs; however, when compounded by the economic impact of NCDs, set against a background of an ageing population and increasing expectations of health care, these factors demonstrate the potential to have unaffordable health services in the future.[@b15-ceor-7-377] Therefore, policymakers need to act both in terms of imposing a combination of shorter-term and longer-term measures, with short-term actions including "incentives and disincentives (such as taxes on tobacco), regulations (for example, limiting the availability of unhealthy food in schools), and clinical interventions (for instance, screening the population for risk factors)".[@b10-ceor-7-377]

Due to the size of the looming financial costs associated with NCDs, there also needs to be a comprehensive set of long-term measures; however, these will be much more difficult for policymakers to implement. These long-term measures must address cultural factors; for example, research has highlighted that the region's culture of hosting guests and eating out, along with its affluent lifestyle, has given rise to a much more sugar-based diet.[@b16-ceor-7-377] Baglar emphasizes the need to change people's perceptions about being a good host, which are deeply entrenched in society, in association with increased education of patients about their Long Term Conditions.[@b16-ceor-7-377]

Chahine et al take the view that a larger set of measures is required to meet these issues in the longer term, and agree that "... programs \[must\] seek to change individual behavior", and further suggest that this needs to be done "... along with regulations and funding in the healthcare system with a stress on preventative care \[to\] educate those who care for children, inform adults, and raise awareness among health providers about NCDs.[@b10-ceor-7-377]"

They conclude that all sectors of the economy have a part to play, commenting that a "... wide range of stakeholders" would need to be involved; for example, the high-tech and food industries have a part to play in improving treatment and prevention through improving patient monitoring systems and more information on food packaging.[@b10-ceor-7-377]

Based on our report, the four top priority diseases identified as needing urgent action are cardiovascular disease, mental and behavior disorders, cancer, and chronic respiratory disease. Most NCDs can be traced back to lifestyle-related factors, such as smoking, diet, and lack of exercise. As such Qatar launched it's National Cancer Strategy (2011--2016), with recommendations covering tobacco cessation and nutrition and physical activity. The Supreme Council of Health launched its first national health strategy in 2011, which addresses the main challenges facing the health care system in Qatar, and highlights the need to move beyond treating the acutely ill and address health care at the prevention stage, with the aim to embed prevention and early intervention into every aspect of the health system, thereby empowering the people of Qatar to be active participants in self-care, prevention, and maintaining wellness.[@b17-ceor-7-377]

The Supreme Council of Health was established in 2009 by Emiri decree. Its main role is to "... oversee and regulate the medical market place and promote high quality health care" through evidence-based policies.[@b18-ceor-7-377] The flagship strategy of the Supreme Council of Health is the Qatar National Health Strategy (NHS) for 2011--2016, which stems from the Qatar National Development Strategy 2030 launched in 2011: "The NHS proposes change across the healthcare system, through a practical national strategy for health reform designed to benefit all people currently living in Qatar as well as future generations." The NHS aims to address all key health issues affecting Qatar and to provide world-class health care for the future by building capacity and increasing quality across the health care sector. It is therefore necessary for the NHS to be working towards addressing the NCDs identified in this research.

Goal three of Qatar's NHS centers on embedding prevention into health service reforms; and focus on high-risk priorities ([Table 5](#t5-ceor-7-377){ref-type="table"}).[@b17-ceor-7-377] Chronic disease management is prioritized within five main projects mentioned in the NHS, ie, a diabetes program, disease management programs, preventative health governance, nutrition and physical activity, mental health design, smoking cessation, a national screening program, and environmental health. Injuries, including road traffic accidents, are not considered in this report as one on the NCDs that need to be prioritized, since they are not included in the definition of NCD.

In conclusion, it is recommended that Qatar address cardiovascular and respiratory diseases in a more comprehensive way, so that we can prevent these diseases in the first place, manage cases appropriately, and prevent or manage the complications that arise. According to the results of the STEPwise survey, nutrition and physical activity as the main interventions that need to be addressed in an effective, innovative way.[@b11-ceor-7-377] Nearly 33% of the population in Qatar has elevated blood pressure (systolic \$140 mmHg and/or diastolic \$90 mmHg)[@b19-ceor-7-377] or is currently on medication for raised blood pressure, according to World Health Organization standards. Given that cardiovascular disease is the highest ranked disease in term of mortality, disability-adjusted life years, and economic burden, hypertension should be approached in a systematic way to be able to coordinate heath care interventions and communicate at both the individual organization and national level. Urgent comprehensive and collaborative efforts are needed, with appropriate monitoring and assessment tools to determine the cost-effectiveness of intervention.
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###### 

Three separate methods were employed to calculate the burden of direct and indirect

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [\*](#tfn1-ceor-7-377){ref-type="table-fn"}Cost-of-illness approach                                        EPIC approach                                                                                                                                                                                                 [\*\*](#tfn2-ceor-7-377){ref-type="table-fn"}VSL approach
  ---------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
  Estimates of direct and indirect costs of ill health for five distinct disease categories are:\            Lost output from all five conditions (cancer, cardiovascular disease, chronic respiratory diseases, diabetes, and mental health) over the period 2011--2030 is estimated at approximately US\$ 47 trillion.   Economic burden of life lost due to all NCDs ranges from US\$ 22.8 trillion in 2010 to US\$ 43.3 trillion in 2030.
  **Cancer:** an estimated US\$ 290 billion in 2010 rising to US\$ 458 billion in 2030.\                                                                                                                                                                                                                                   
  **Cardiovascular disease:** an estimated US\$ 863 billion in 2010 rising to US\$ 1.04 trillion in 2030.\                                                                                                                                                                                                                 
  **COPD:** an estimated US\$ 2.1 trillion in 2010 US\$ rising to US\$ 4.8 trillion in 2030.\                                                                                                                                                                                                                              
  **Diabetes:** an estimated nearly US\$ 500 billion in 2010 rising to at least US\$ 745 billion in 2030.\                                                                                                                                                                                                                 
  **Mental illness:** an estimated US\$ 2.5 trillion in 2010 rising to US\$ 6.0 trillion by 2030.                                                                                                                                                                                                                          

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

The cost as the sum of direct and indirect costs (including personal medical; non-medical costs, and income losses);

Value of statistical life (VSL) approach (reflects a population's willingness to pay to reduce the risk of disability or death associated). Reproduced with permission from Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S., Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B., Stein, A.Z., & Weinstein, C. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.[@b6-ceor-7-377]

**Abbreviations:** COPD, chronic obstructive pulmonary disease; NCDs, noncommunicable diseases; VSL, value of statistical life; EPIC, European Prospective Investigation into Cancer and Nutrition.

###### 

Economic burden of noncommunicable diseases for 2011--2013 (trillions of US\$), based on the EPIC[\#](#tfn5-ceor-7-377){ref-type="table-fn"} model

  Country income group   Diabetes   Cardiovascular diseases   Chronic respiratory diseases   Cancer   Mental illness[\*](#tfn4-ceor-7-377){ref-type="table-fn"}   Total
  ---------------------- ---------- ------------------------- ------------------------------ -------- ----------------------------------------------------------- -------
  High                   0.9        8.5                       1.6                            5.4      9.0                                                         25.5
  Upper-middle           0.6        4.8                       2.2                            2.3      5.1                                                         14.9
  Lower-middle           0.2        2.0                       0.9                            0.5      1.9                                                         5.5
  Low                    0.0        0.3                       0.1                            0.1      0.3                                                         0.9
  LIMIC                  0.8        7.1                       3.2                            2.9      7.3                                                         21.3
  World                  1.7        15.6                      4.8                            8.3      16.3                                                        46.7

**Notes:**

Numbers for mental illness were obtained by relating the economic burden of all other diseases to their associated number of disability-adjusted life years; the burden for mental illness was then projected using the relative size of the corresponding disability-adjusted life year numbers to all other conditions.

Lost output from all five conditions (cancer, cardiovascular disease, chronic respiratory diseases, diabetes and mental health) over the period 2011--2030 is estimated at approximately US\$ 47 trillion. Reproduced with permission from Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S., Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B., Stein, A.Z., & Weinstein, C. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.[@b6-ceor-7-377]

**Abbreviations:** LIMIC, less indebted middle income countries; EPIC, European Prospective Investigation into Cancer and Nutrition.

###### 

Noncommunicable disease mortality and DALY criteria

  Diseases                                          [\*](#tfn8-ceor-7-377){ref-type="table-fn"}Mortality rate   [\*\*](#tfn9-ceor-7-377){ref-type="table-fn"}DALY
  ------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------
  Cardiovascular diseases (IHD and stroke)          1                                                           1
  Cancer (lung, including tracheal and bronchial)   2                                                           3
  Respiratory diseases (COPD)                       3                                                           4
  Mental and behavioral disorders                   --                                                          2
  Diabetes                                          5                                                           5

**Notes:** Table represents the ranking of these diseases in the order they appear regionally;

Death rate per 100,000 population;

Disability Adjusted Life Years, the sum of years of potential life lost due to premature mortality and the years of productive life lost due to disability.

**Abbreviations:** COPD, chronic obstructive pulmonary disease; DALY, disability-adjusted life years; IHD, ischemic heart disease.

###### 

Regional ranking of noncommunicable diseases according to economic burden criteria

  Diseases                                          Cost of illness   Anticipated economic burden based on EPIC[\#](#tfn11a-ceor-7-377){ref-type="table-fn"} approach 2011--2030   Output losses using VSL approach (2010 and 2030)   
  ------------------------------------------------- ----------------- ------------------------------------------------------------------------------------------------------------ -------------------------------------------------- ---
  Cardiovascular diseases (IHD and stroke)          1                 2                                                                                                            2                                                  2
  Cancer (lung, including tracheal and bronchial)   5                 1                                                                                                            3                                                  3
  Respiratory diseases (COPD)                       4                 4                                                                                                            4                                                  4
  Mental and behavioral disorders                   3                 3                                                                                                            1                                                  1
  Diabetes                                          2                 5                                                                                                            5                                                  5

**Note:** Table represents the ranking of these diseases in the order they appear regionally.

Lost output from all five conditions (cancer, cardiovascular disease, chronic respiratory diseases, diabetes and mental health) over the period 2011-2030 is estimated at approximately US\$ 47 trillion. Reproduced with permission from Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S., Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B., Stein, A.Z., & Weinstein, C. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.[@b6-ceor-7-377]

**Abbreviations:** COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease; VSL, value of statistical life; EPIC, European Prospective Investigation into Cancer and Nutrition.

###### 

Summary of high-impact disease in the Gulf region

  Diseases                                                       Mortality rate[\*](#tfn14-ceor-7-377){ref-type="table-fn"}   DALY[\*\*](#tfn15-ceor-7-377){ref-type="table-fn"}   Comparative Lost Output[\*\*\*](#tfn16-ceor-7-377){ref-type="table-fn"}
  -------------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------- -------------------------------------------------------------------------
  Cardiovascular diseases (ischemic heart disease & stroke)      1                                                            1                                                    33%
  Cancer (Lung cancers including trachea and bronchus cancers)   2                                                            3                                                    18%
  Respiratory diseases (COPD)                                    3                                                            4                                                    10%
  Mental and behavior disorders                                  --                                                           2                                                    35%
  Diabetes                                                       5                                                            5                                                    6%

**Notes:** Table represents the ranking of these diseases in the order they appear regionally.

Death rate per 100 000 population.

The sum of years of potential life lost due to premature mortality and the years of productive life lost due to disability.

Quantifies global economic losses from NCDs by relating projected NCD mortality rates in a population to current and future economic output at the national level.

**Abbreviations:** DALY, disability-adjusted life years; COPD, chronic obstructive pulmonary disease; NCDs, noncommunicable diseases.
